NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 17.30
+0.30 (1.76%)
Jul 14, 2026, 10:31 AM CST
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 834.71 million as of July 14, 2026. Its market cap has decreased by -35.97% in one year.
Market Cap
834.71M
Enterprise Value
392.24M
Revenue
176.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.30
Market Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 834.71M, an increase of 191.93%. That is a compound annual growth rate of 5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 834.71M | -16.52% |
| Dec 31, 2025 | 999.93M | -18.70% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.03B |
| Holy Stone Healthcare | 1.00B |
| GeneReach Biotechnology | 974.15M |
| U-Neuron Biomedical | 973.67M |
| TCI GENE | 965.74M |
| Meribank Biotech | 957.84M |
| Taiwan Advance Bio-Pharmaceutical | 904.50M |
| BioLASCO Taiwan | 760.68M |